SCHEMBL7684256

SCHEMBL7684256

O=C1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(Cc2ccc(C(F)(F)F)cc2)C1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 10/20 0.55
RHOC P08134 1/20 0.45
RHOA P61586 1/20 0.45
TACR3 P29371 1/20 0.45
CNR1 P21554 1/20 0.42
KMT2A Q03164 1/20 0.39
OPRD1 P41143 1/20 0.39
USP2 O75604 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
OPRK1 P41145 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL730772 0.92 TACR1 (0.66) TACR1RHOCRHOATACR3OPRD1
SCHEMBL7688875 0.89 TACR1 (0.49) TACR1RHOCRHOATACR3USP2
SCHEMBL12809194 0.88 OPRK1 (0.52) TACR1RHOCRHOATACR3OPRK1
SCHEMBL4987212 0.88 TACR1 (0.49) TACR1RHOCRHOATACR3USP2
SCHEMBL4987525 0.87 TACR1 (0.48) TACR1RHOCRHOATACR3USP2
SCHEMBL7864817 0.86 TACR1 (0.48) TACR1KMT2A
SCHEMBL3076567 0.81 KMT2A (0.44) KMT2AOPRD1CYP3A4OPRK1CYP2C19
SCHEMBL4983555 0.81 TACR1 (0.62) TACR1RHOCRHOATACR3OPRD1
SCHEMBL7863763 0.80 L3MBTL1 (0.56) TACR1RHOCRHOATACR3L3MBTL1
SCHEMBL5368900 0.80 L3MBTL1 (0.56) TACR1RHOCRHOATACR3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346540-B1 SUBSTANCE P ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM, PSYCHOLOGICAL AND BRAIN DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 2002-02-12 US disclosed
EP-0855999-B1 1-(1,2-DISUBSTITUTED PIPERIDINYL)-4-SUBSTITUTED PIPERIDINE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2001-10-04 EP disclosed
US-6169097-B1 1-(1,2-Disubstituted piperidinyl)-4-substituted piperidine derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2001-01-02 US disclosed
EP-0855999-A1 1-(1,2-DISUBSTITUTED PIPERIDINYL)-4-SUBSTITUTED PIPERIDINE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 1998-08-05 EP disclosed
WO-1997024324-A1 1-(1,2-DISUBSTITUTED PIPERIDINYL)-4-SUBSTITUTED PIPERIDINE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 1997-07-10 WO disclosed